First and only FDA-approved therapy for advanced* PPGL
Ready. Steady. Now.
Be ready when pheochromocytoma and paraganglioma (PPGL) advances.
Deliver both steady symptom relief and sustained tumor response.
Learn about AZEDRA
View AZEDRA efficacy and safety data
Review patient cases
See if AZEDRA could be right for your patients
Get your patients started on AZEDRA
Download the Treatment Request Form
Advanced PPGL includes unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma requiring systemic anticancer therapy.